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While few people would deny theappeal of a day in the sun there
are some who seem to take it too far. In
recent years the concept of ‘tanning
addiction’ has become popular and sev-
eral studies have supported the notion of
viewing exposure to UV radiation as a
form of substance abuse. In this article
we will review some of the literature on
sun seeking behavior.
Evidence exists for both physiological
dependence, characterized by tolerance
and withdrawal, and addiction, as mod-
eled on work from the Alcoholism field.
In 1992 a multidisciplinary committee of
the National Council on alcoholism and
Drug Dependence and the American Soci-
ety of Addiction Medicine defined the
hallmarks of Alcoholism as “It (Alcohol-
ism) is characterized by impaired control
over drinking, preoccupation with the
drug alcohol, use of alcohol despite
adverse consequences, and distortions in
thinking, most notably denial..”1 Several
studies have used modified Alcoholism
surveys to probe tanning addiction.
While the most common source of UV
(UV) light is the sun, in recent decades use
of indoor tanning parlors has become a sig-
nificant source of UV exposure. Visits to
indoor tanning parlors are easier to quan-
tify than time in the sun, so many studies
have focused on indoor tanners. In 2003 a
study of non-Hispanic white adolescents in
the USA reported that »28% of female
adolescents had used a tanning booth at
least 3 times and this percentage increased
with age to »47% in 18 to 19 y old
women.2 A recent meta-analysis of cancer
risk from indoor tanning found that indoor
tanning, particularly under age 25, is asso-
ciated with a greater risk of developing
both squamous and basal cell carcinoma.3
The study estimated that greater than 170,
000 cases of non-melanoma skin cancer are
attributable to indoor tanning each year.
Indoor tanning has also been shown to
increase risk of melanoma.4 Despite these
serious risks, indoor tanning remains
highly popular among young people. These
high rates of indoor tanning are likely to be
driven in part or initiated by cosmetic
desires. Since the early 1900s having a ‘tan’
has been regarded as a sign of health
and prosperity in the Western world.5
However, given the availability of spray-on
tanning products which can substitute the
cosmetic results, and the widespread
knowledge of the dangers of tanning, could
there be another driving factor?
A study in 2005 administered two ques-
tionnaires to beach goers, a modified ver-
sion of the CAGE questionnaire,
(originally designed for alcoholism: Cut
down, Annoyed, Guilty, Eye-opener), and
the American Psychiatric Association’s
Diagnostic and Statistical Manuel of
Mental Disorders criteria for substance
abuse, (DMS). From the results of these
questionnaires they found that 26% of
respondents meet the modified CAGE cri-
teria for substance abuse, responding posi-
tively for 2 or more of the addiction
hallmarks. 53% meet the DSM criteria
responding positively to 3 or more of 7
addiction signs.6 Similar numbers were
found by 2 other studies of college students
in the Northeastern USA who reported
using indoor tanning facilities, and fre-
quent tanners recruited from tanning sal-
ons in Dallas, Texas.7,8 In the Dallas study
the most commonly cited reasons for tan-
ning were ‘to look good’ (90%), ‘to feel
good’ (69%) and for relaxation (56%),
suggesting a subjective and potentially
reinforcing response to UV exposure.7
27% of respondents answered positively to
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needing to spend increasing time tanning
to maintain their tan, and 45% to feeling
unattractive or anxious to tan if they did
not maintain their tan, suggesting toler-
ance and withdrawal respectively.
Further, respondents who had started
tanning at a younger age were more likely
to match criteria for a tanning addictive
disorder, paralleling other addictions such
as alcohol, nicotine and cannabis.9-11
Given that b endorphin is known to be
expressed in the skin, it was speculated
that it may be involved in the reinforcing
effects. The first data to support endoge-
nous opiates as the mediators of this
response came from a small randomized
controlled study which exposed 8 frequent
and 8 infrequent tanners to either a nor-
mal UV tanning bed, or a control tanning
bed with no UV.12 After exposure, partici-
pants rated their preference for the partic-
ular tanning bed they had used. Frequent
tanners showed a stronger preference for
the ‘real’ tanning bed over the one with
mock UV than infrequent tanners, though
both groups showed some preference.
This was repeated with prior administra-
tion of naltrexone, a broad opioid antago-
nist. In both the frequent tanners and
infrequent tanners naltrexone reduced the
preference for the UV tanning bed. At a
moderate naltrexone dose (15mg) 4 of the
8 frequent tanners reported adverse effects
resembling opioid withdrawal, (nausea,
jitteriness), while none of the infrequent
tanners reported adverse effects. Surpris-
ingly, none of the frequent tanners
reported adverse effects after a higher nal-
trexone dose (25 mg). This provides evi-
dence for both a reinforcing opioid
mechanism and physiological dependence
in response to UV radiation.
While some studies have found
increased levels of b-endorphin in the
blood of volunteers after UV exposure,
results have been mixed.13-16 Studies in
humans are complicated by many varia-
bles both between each individual, and
from day to day within an individual. Fur-
ther, these experiments are complicated by
the known risks of administering UV.
Using mice our laboratory observed that
daily sub erythemic UV exposure pro-
duced a systemic rise in blood b endor-
phin levels.17 Further this increase was
physiologically significant and caused
analgesia which was absent in b endor-
phin null mice, or mice lacking skin
expression of p53, the upstream regulator
of b endorphin in the tanning pathway.
Administration of naloxone caused opiate
withdrawal symptoms and conditioned
place aversion in UV treated mice, but not
in mock treated mice, b endorphin null
mice or p53 conditional knockouts. We
also observed that peripherally adminis-
tered b endorphin is capable of causing
conditioned place preference, suggesting
that skin derived b endorphin could have
central nervous system effects. While we
have only shown this response in mice,
other aspects of the UV response and tan-
ning pathways are known to be conserved
between mice and humans.
While the putative tanning addiction is
clearly not of the same strength as addic-
tion to illicit drugs such as heroin or
methamphetamine, this does not render
tanning addiction trivial. The FDA esti-
mates that indoor tanning lamps produce
over 3000 hospital emergency room visits
per year.18 In a survey of adolescent tan-
ning salon users, 57% reported having
experienced burns in the last year.19 In a
survey of frequent tanners 9 out of 100
respondents reported having tried to stop
tanning but still continuing, and 6
reported missing a social engagement,
work, school or other recreation activity
to go tanning.7 Frighteningly 34% contin-
ued tanning despite reporting having had
a skin cancer, or having a family history of
skin cancer.
These results were mirrored in a recent
study where basal cell carcinoma patients
with a history of indoor tanning use were
contacted 1 to 4 y after treatment and
asked about their tanning habits. Of those
who responded,15% reported having used
indoor tanning within the last year, with a
median of 10 sessions in that time.20
Similar results have also been seen in mela-
noma survivors. A study in 2012 found
that fewer than 50% of melanoma survi-
vors reported regular sunscreen use and
sun avoidance, and 10 patients (of 156)
reported using tanning beds after being
diagnosed with melanoma.21 Regulation
of indoor tanning is currently a controver-
sial topic. While many medical organiza-
tions have recommended stricter
regulations or an outright ban, these have
come up against lobbying by the multibil-
lion dollar tanning industry.22 The
American Academy of Dermatology sup-
ports a total ban on non-medical manufac-
ture and sale of indoor tanning
technology. While some states in the US
have banned commercial indoor tanning
for minors, several companies offer home
tanning beds. Several studies have shown
high rates of non-adherence to existing reg-
ulations within the tanning industry. A
survey of patron records in North Carolina
found that 95% of indoor tanning patrons
exceeded the Federal Drug Adminis-
tration’s recommended limits.23 A study in
San Diego found that only 5% of tanning
establishments adhered to recommended
tanning schedules and all offered
‘unlimited’ tanning options.24 Another
study, also in San Diego, found that only
43% of tanning establishments complied
with parental consent regulations.25 While
UV exposure is a source of Vitamin D,
readily available supplements and fortified
foods mean UV is no longer a necessity.
Tanning would certainly not be the first
behavior to have been recommended for its
health benefits before being known to be
addictive as well as carcinogenic.
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